Three-month tapering and discontinuation of long- term, low-dose glucocorticoids in senior patients with rheumatoid arthritis is feasible and safe: placebo-controlled double blind tapering after the GLORIA trial

Abdullah Ali Hadi Almayali, Maarten Boers, Linda Hartman, Daniela Opriș-Belinski, Reinhard Bos, Marc R. Kok, José António Pereira da Silva, E. N. Griep, Ruth Klaasen, Cornelia F Allaart, Paul Baudoin, Hennie G. Raterman, Zoltán Szekanecz, Frank Buttgereit, P. Masaryk, Willem F. Lems, Yvo M. Smulders, Maurizio Cutolo, Marieke M. ter Wee